Our flagship platform eliminates demographic bias in healthcare AI while maintaining clinical accuracy. Patent filing October 2025. Using SHAP-based analysis and dual-objective optimization, FairTrace ensures AI-driven clinical decisions are both accurate and equitable. Traditional medicine practitioners contribute cultural context that enhances bias detection. Target: <5% demographic bias while maintaining 95%+ clinical accuracy Market: Healthcare systems, insurance companies, clinical research organizations

Status: 82% Complete | Production Launch Q1 2026 | Patent Filed September 2025. Validates traditional medicine practices through appropriation-risk scoring and cultural context preservation. VeriTrad ensures traditional knowledge is properly attributed and protected while enabling scientific research partnerships. Target: 97%+ traditional knowledge attribution accuracy in <10 seconds Market: Pharmaceutical companies, academic research institutions, tribal governments

Status: Architecture Defined | Development Q1 2026 | Patent Filing November 2025. Discovers and optimizes botanical therapeutics through multi-compound chemical analysis and neuropsychiatric profiling. Connects traditional botanical knowledge with molecular-level validation for cannabis therapeutics and plant medicine. Target: 90%+ prediction accuracy for botanical therapeutic effects Market: Cannabis industry, pharmaceutical companies, botanical researchers